tiprankstipranks
NKGen Biotech (NKGN)
NASDAQ:NKGN
US Market

NKGen Biotech (NKGN) Financial Statements

Compare
87 Followers

NKGen Biotech Financial Overview

NKGen Biotech's market cap is currently $18.35M. The company's EPS TTM is $-4.922; its P/E ratio is ―; NKGen Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 77.00K$ 426.00K
Gross Profit$ -1.20M$ 59.00K$ 396.00K
Operating Income$ -29.75M$ -24.35M$ -21.86M
EBITDA$ -28.54M$ -23.23M$ -20.70M
Net Income$ -82.95M$ -26.75M$ -23.27M
Balance Sheet
Cash & Short-Term Investments$ 26.00K$ 117.00K$ 351.00K
Total Assets$ 16.48M$ 16.33M$ 18.07M
Total Debt$ 19.92M$ 12.03M$ 51.97M
Net Debt$ 19.89M$ 11.92M$ 51.62M
Total Liabilities$ 75.17M$ 14.77M$ 56.12M
Stockholders' Equity$ -58.69M$ 1.56M$ -38.05M
Cash Flow
Free Cash Flow$ -22.00M$ -22.72M$ -20.01M
Operating Cash Flow$ -21.95M$ -22.56M$ -19.55M
Investing Cash Flow$ -48.00K$ -163.00K$ -459.00K
Financing Cash Flow$ 22.16M$ 22.49M$ 20.16M
Currency in USD

NKGen Biotech Earnings and Revenue History

NKGen Biotech Debt to Assets

NKGen Biotech Cash Flow

NKGen Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis